(Q45885096)

17 December 2017

title

Experience of prophylaxis treatment in children with severe haemophilia (English)

1 reference

17 December 2017

0 references

Yee TT

1

1 reference

17 December 2017

Beeton K

2

1 reference

17 December 2017

Griffioen A

3

1 reference

17 December 2017

Harrington C

4

1 reference

17 December 2017

Miners A

5

1 reference

17 December 2017

Lee CA

6

1 reference

17 December 2017

Brown SA

7

1 reference

17 December 2017

language of work or name

1 reference

1 March 2002

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

76-82

1 reference

17 December 2017

Considerations for current and future management of haemophilia and its complications

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

Haemophilia prophylaxis in young patients--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

The impact of prophyactic treatment on children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

GUIDELINES ON THERAPEUTIC PRODUCTS TO TREAT HAEMOPHILIA AND OTHER HEREDITARY COAGULATION DISORDERS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

Joint evaluation instruments for children and adults with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

The use of central venous catheters (portacaths) in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

The use of the Port-A-Cath in children with haemophilia--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

Factor VIII inhibitors in haemophiliacs: a single-centre experience over 34 years, 1964-97.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

Primary prophylaxis for individuals with severe haemophilia: how many hospital visits could treatment prevent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00630.X

10.1046/J.1365-2516.2002.00630.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

11952841

1 reference

17 December 2017